Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives.
Oncology • Precision Medicine • Targeted Therapeutics • Biomarkers • Solid Tumors
51 - 200
💰 $125M Post-IPO Debt on 2022-11
April 21
April 21
51 - 200
🇺🇸 United States – Remote
💵 $220k - $294k / year
💰 $125M Post-IPO Debt on 2022-11
⏱ Part Time
🟠 Senior
💼 Legal
April 10
51 - 200
🇺🇸 United States – Remote
💵 $213.4k - $225.2k / year
💰 $125M Post-IPO Debt on 2022-11
⏱ Part Time
🟠 Senior
🔧 QA Engineer
April 10
51 - 200
🇺🇸 United States – Remote
💵 $210k - $232k / year
💰 $125M Post-IPO Debt on 2022-11
⏱ Part Time
🔴 Lead
📈 Performance Marketing